Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-10-18 5:23 pm Purchase | 13D | Tango Therapeutics Inc. TNGX | BCTG Holdings LLC | 15,214,053 15.000% | 1,075,000 (+7.60%) | View |
| 2023-08-16 4:40 pm Purchase | 13D | Tango Therapeutics Inc. TNGX | BCTG Holdings LLC | 14,139,053 13.900% | 7,150,603 (+102.32%) | View |
| 2022-01-04 5:03 pm Unchanged | 13D | Tango Therapeutics Inc. TNGX | BCTG Holdings LLC | 6,988,450 8.000% | 0 (Unchanged) | View |
| 2021-08-20 4:31 pm Purchase | 13D | Tango Therapeutics Inc. TNGX | BCTG Holdings LLC | 6,988,450 8.300% | 6,988,450 (New Position) | View |
| 2021-02-16 4:35 pm Purchase | 13G | Tango Therapeutics Inc. TNGX | BCTG Holdings LLC | 4,488,450 21.000% | 4,488,450 (New Position) | View |